New York State Common Retirement Fund’s Trillium Therapeutics Inc. TRIL Stock Holding History

New York State Common Retirement Fund’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-70,738	Closed	-$1.24M	–	3393
2021 Q3	$1.24M	Sell	70,738 -13,062	-16%	-$153K	﹤0.01%	2023
2021 Q2	$813K	Buy	+83,800	New	+$789K	﹤0.01%	2327
2016 Q1	–	Sell	-2,727	Closed	-$34K	–	3163
2015 Q4	$34K	Hold	2,727	–	–	﹤0.01%	3135
2015 Q3	$36K	Buy	+2,727	New	+$50.1K	﹤0.01%	3137

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

New York State Common Retirement Fund's TRIL Position: Q4 2021 in Review

New York State Common Retirement Fund sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 70,738 shares — an estimated $1.24M sold.

New York State Common Retirement Fund first reported a position in TRIL in Q3 2015 and held it in 4 quarters. The position peaked at $1.24M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

New York State Common Retirement Fund reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
New York State Common Retirement Fund sold 70,738 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $1.24M.
New York State Common Retirement Fund first reported a position in Trillium Therapeutics Inc. in Q3 2015 and held it in 4 quarters.
New York State Common Retirement Fund's Trillium Therapeutics Inc. position peaked at $1.24M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on New York State Common Retirement Fund's 13F filing for Q4 2021, filed 2 Feb 2022.